Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 1 1

Status

Active not recruiting 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Genitourinary 4Gastrointestinal 1

Conditions

Prostatic Neoplasms 747Carcinoma, Renal Cell 237Urinary Bladder Neoplasms 212Carcinoma, Transitional Cell 115Breast Neoplasms 100Kidney Neoplasms 97Neoplasms 91Carcinoma, Non-Small-Cell Lung 86Melanoma 82Ovarian Neoplasms 81Colorectal Neoplasms 76Neoplasm Metastasis 69Non-Muscle Invasive Bladder Neoplasms 58Lung Neoplasms 58Pancreatic Neoplasms 49Endometrial Neoplasms 46Sarcoma 43Stomach Neoplasms 42Uterine Cervical Neoplasms 41Carcinoma, Hepatocellular 36Adenocarcinoma 35Wilms Tumor 33Esophageal Neoplasms 33Triple Negative Breast Neoplasms 31Squamous Cell Carcinoma of Head and Neck 31Head and Neck Neoplasms 29Testicular Neoplasms 25Metastatic Castration-resistant Prostate Cancer 25Disease 24Colonic Neoplasms 24

Interventions

testosterone 17 beta-cypionate 1pembrolizumab 1enfortumab vedotin 1Testosterone Propionate 1Standard of Care 1Radiation Dose Hypofractionation 1Practice Guidelines as Topic 1Mitomycin 1Methyltestosterone 1Gemcitabine 1Fluorouracil 1Cisplatin 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Urologic Diseases × Genitourinary × 90 days × Clear all
NCT04731376 2026-05-26

Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone

Emory University

Phase 1 Active not recruiting
56 enrolled
Genitourinary

Hypogonadism, Urologic Diseases, Urologic Neoplasms

NCT03933826 2026-05-12

CISTO

University of Washington

Active not recruiting
570 enrolled 27 charts
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Neoplasms, Neoplasms by Site, Recurrence, Urogenital Neoplasms, Urologic Diseases

NCT07566156 2026-05-11

EV-309

Astellas Pharma Inc

Phase 3 Recruiting
390 enrolled
Genitourinary

Urogenital Diseases, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasms, Neoplasms by Site, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms, Female Urogenital Diseases, Male Urogenital Diseases

NCT07483658 2026-03-19

HYP-OP-RT

CHU de Quebec-Universite Laval

Phase NA Not yet recruiting
434 enrolled
GastrointestinalGenitourinary

Gastrointestinal Diseases, Neoplasm Recurrence, Local, Prostatic Neoplasms, Radiation Injuries, Urologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡